Position in ALT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,305,640
-$82,152 QoQ
Shares Held
758,435
-2.2% QoQ
Ownership
0.390%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ALT ranks #202 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ALT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,305,640 | 758,435 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,387,792 | 775,258 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,909,181 | 1,359,885 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $5,621,251 | 1,491,049 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $3,233,021 | 835,407 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,286,235 | 657,247 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,646,333 | 921,822 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $7,954,889 | 1,295,585 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $8,585,278 | 1,291,020 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $22,517,627 | 2,211,948 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $11,710,134 | 1,040,901 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,258,548 | 484,058 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $3,814,506 | 1,080,598 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,314,893 | 785,521 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,148,901 | 434,584 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,558,686 | 591,910 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,076,077 | 1,374,024 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $8,574,346 | 1,407,939 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $10,555,458 | 1,152,343 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,163,601 | 721,804 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,638,949 | 775,528 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $1,095,640 | 77,540 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $753,356 | 66,787 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $361,125 | 27,358 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $208,695 | 19,486 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $24,787 | 7,722 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||